GO:0030134 | COPII-coated ER to Golgi transport vesicle | 7.69% (7/91) | 6.8 | 0.0 | 0.0 |
GO:0016020 | membrane | 61.54% (56/91) | 1.13 | 0.0 | 0.0 |
GO:0030135 | coated vesicle | 9.89% (9/91) | 4.59 | 0.0 | 0.0 |
GO:0031090 | organelle membrane | 38.46% (35/91) | 1.58 | 0.0 | 0.0 |
GO:0016192 | vesicle-mediated transport | 17.58% (16/91) | 2.74 | 0.0 | 1e-06 |
GO:0098796 | membrane protein complex | 15.38% (14/91) | 2.98 | 0.0 | 1e-06 |
GO:0005575 | cellular_component | 89.01% (81/91) | 0.54 | 0.0 | 1e-06 |
GO:0051641 | cellular localization | 24.18% (22/91) | 2.03 | 0.0 | 3e-06 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 6.59% (6/91) | 5.29 | 0.0 | 3e-06 |
GO:0051179 | localization | 36.26% (33/91) | 1.44 | 0.0 | 7e-06 |
GO:0070727 | cellular macromolecule localization | 20.88% (19/91) | 2.14 | 0.0 | 1e-05 |
GO:0060341 | regulation of cellular localization | 13.19% (12/91) | 2.9 | 0.0 | 1.5e-05 |
GO:0110165 | cellular anatomical entity | 85.71% (78/91) | 0.51 | 0.0 | 1.8e-05 |
GO:0032880 | regulation of protein localization | 12.09% (11/91) | 3.01 | 0.0 | 2.2e-05 |
GO:0016021 | integral component of membrane | 26.37% (24/91) | 1.72 | 0.0 | 2.2e-05 |
GO:0005789 | endoplasmic reticulum membrane | 15.38% (14/91) | 2.5 | 0.0 | 2.5e-05 |
GO:0034976 | response to endoplasmic reticulum stress | 8.79% (8/91) | 3.74 | 0.0 | 2.6e-05 |
GO:0048193 | Golgi vesicle transport | 9.89% (9/91) | 3.39 | 0.0 | 3e-05 |
GO:0033036 | macromolecule localization | 20.88% (19/91) | 1.98 | 0.0 | 3.1e-05 |
GO:0008104 | protein localization | 18.68% (17/91) | 2.13 | 0.0 | 3.3e-05 |
GO:0009987 | cellular process | 78.02% (71/91) | 0.58 | 0.0 | 3.7e-05 |
GO:0008150 | biological_process | 85.71% (78/91) | 0.48 | 0.0 | 4e-05 |
GO:0006886 | intracellular protein transport | 13.19% (12/91) | 2.64 | 1e-06 | 5.3e-05 |
GO:0046907 | intracellular transport | 16.48% (15/91) | 2.25 | 1e-06 | 5.5e-05 |
GO:0035102 | PRC1 complex | 3.3% (3/91) | 7.33 | 1e-06 | 6.6e-05 |
GO:0051649 | establishment of localization in cell | 17.58% (16/91) | 2.12 | 1e-06 | 6.8e-05 |
GO:0051234 | establishment of localization | 30.77% (28/91) | 1.41 | 1e-06 | 7.2e-05 |
GO:0003674 | molecular_function | 83.52% (76/91) | 0.48 | 1e-06 | 7.6e-05 |
GO:0031410 | cytoplasmic vesicle | 19.78% (18/91) | 1.92 | 1e-06 | 7.8e-05 |
GO:0006810 | transport | 29.67% (27/91) | 1.42 | 1e-06 | 9.5e-05 |
GO:0031982 | vesicle | 20.88% (19/91) | 1.82 | 1e-06 | 9.6e-05 |
GO:0097708 | intracellular vesicle | 19.78% (18/91) | 1.88 | 1e-06 | 0.000106 |
GO:0031224 | intrinsic component of membrane | 26.37% (24/91) | 1.52 | 2e-06 | 0.00011 |
GO:0019538 | protein metabolic process | 32.97% (30/91) | 1.29 | 2e-06 | 0.000111 |
GO:0070201 | regulation of establishment of protein localization | 8.79% (8/91) | 3.31 | 2e-06 | 0.000112 |
GO:0031519 | PcG protein complex | 4.4% (4/91) | 5.32 | 3e-06 | 0.000214 |
GO:0010008 | endosome membrane | 8.79% (8/91) | 3.16 | 3e-06 | 0.000222 |
GO:0005801 | cis-Golgi network | 4.4% (4/91) | 5.19 | 5e-06 | 0.000291 |
GO:1901565 | organonitrogen compound catabolic process | 14.29% (13/91) | 2.19 | 5e-06 | 0.000325 |
GO:0016740 | transferase activity | 34.07% (31/91) | 1.18 | 5e-06 | 0.00033 |
GO:0030659 | cytoplasmic vesicle membrane | 10.99% (10/91) | 2.6 | 6e-06 | 0.000364 |
GO:0097027 | ubiquitin-protein transferase activator activity | 3.3% (3/91) | 6.33 | 7e-06 | 0.000387 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 5.49% (5/91) | 4.22 | 8e-06 | 0.000415 |
GO:0051223 | regulation of protein transport | 7.69% (7/91) | 3.3 | 8e-06 | 0.00042 |
GO:1902532 | negative regulation of intracellular signal transduction | 8.79% (8/91) | 3.01 | 7e-06 | 0.000421 |
GO:0098852 | lytic vacuole membrane | 6.59% (6/91) | 3.67 | 8e-06 | 0.000432 |
GO:0032991 | protein-containing complex | 29.67% (27/91) | 1.26 | 9e-06 | 0.000464 |
GO:0012506 | vesicle membrane | 10.99% (10/91) | 2.54 | 9e-06 | 0.000471 |
GO:0043170 | macromolecule metabolic process | 42.86% (39/91) | 0.94 | 1e-05 | 0.000517 |
GO:0043066 | negative regulation of apoptotic process | 8.79% (8/91) | 2.93 | 1.1e-05 | 0.000529 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 5.49% (5/91) | 4.1 | 1.2e-05 | 0.000549 |
GO:0015031 | protein transport | 13.19% (12/91) | 2.18 | 1.3e-05 | 0.000623 |
GO:0043086 | negative regulation of catalytic activity | 8.79% (8/91) | 2.87 | 1.5e-05 | 0.000681 |
GO:0030163 | protein catabolic process | 9.89% (9/91) | 2.61 | 1.7e-05 | 0.000775 |
GO:0098588 | bounding membrane of organelle | 21.98% (20/91) | 1.49 | 2e-05 | 0.000895 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 5.49% (5/91) | 3.9 | 2.3e-05 | 0.000991 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 3.3% (3/91) | 5.75 | 2.4e-05 | 0.001017 |
GO:0036503 | ERAD pathway | 5.49% (5/91) | 3.87 | 2.5e-05 | 0.001021 |
GO:0098791 | Golgi apparatus subcompartment | 10.99% (10/91) | 2.37 | 2.5e-05 | 0.001024 |
GO:0045184 | establishment of protein localization | 13.19% (12/91) | 2.09 | 2.5e-05 | 0.001038 |
GO:0005488 | binding | 71.43% (65/91) | 0.51 | 2.7e-05 | 0.001076 |
GO:0032879 | regulation of localization | 16.48% (15/91) | 1.78 | 2.7e-05 | 0.001076 |
GO:0030970 | retrograde protein transport, ER to cytosol | 3.3% (3/91) | 5.63 | 3.1e-05 | 0.001142 |
GO:1903513 | endoplasmic reticulum to cytosol transport | 3.3% (3/91) | 5.63 | 3.1e-05 | 0.001142 |
GO:0015774 | polysaccharide transport | 2.2% (2/91) | 7.75 | 3.2e-05 | 0.001164 |
GO:1902494 | catalytic complex | 16.48% (15/91) | 1.76 | 3.2e-05 | 0.001173 |
GO:0007033 | vacuole organization | 6.59% (6/91) | 3.34 | 3e-05 | 0.001176 |
GO:0003824 | catalytic activity | 53.85% (49/91) | 0.71 | 3.3e-05 | 0.001184 |
GO:0007030 | Golgi organization | 5.49% (5/91) | 3.76 | 3.6e-05 | 0.001254 |
GO:0008021 | synaptic vesicle | 4.4% (4/91) | 4.44 | 3.6e-05 | 0.001255 |
GO:0043069 | negative regulation of programmed cell death | 8.79% (8/91) | 2.68 | 3.7e-05 | 0.001258 |
GO:1903829 | positive regulation of protein localization | 6.59% (6/91) | 3.26 | 4.1e-05 | 0.001386 |
GO:0060576 | intestinal epithelial cell development | 2.2% (2/91) | 7.42 | 5.3e-05 | 0.001778 |
GO:0042981 | regulation of apoptotic process | 9.89% (9/91) | 2.4 | 5.5e-05 | 0.001808 |
GO:0030162 | regulation of proteolysis | 8.79% (8/91) | 2.58 | 6e-05 | 0.00195 |
GO:0044238 | primary metabolic process | 51.65% (47/91) | 0.7 | 7e-05 | 0.002154 |
GO:2001233 | regulation of apoptotic signaling pathway | 5.49% (5/91) | 3.56 | 7e-05 | 0.002172 |
GO:0046928 | regulation of neurotransmitter secretion | 3.3% (3/91) | 5.24 | 6.9e-05 | 0.002189 |
GO:0051588 | regulation of neurotransmitter transport | 3.3% (3/91) | 5.24 | 6.9e-05 | 0.002189 |
GO:0044092 | negative regulation of molecular function | 9.89% (9/91) | 2.34 | 7.5e-05 | 0.00227 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 6.59% (6/91) | 3.05 | 9.1e-05 | 0.002743 |
GO:0032580 | Golgi cisterna membrane | 3.3% (3/91) | 5.08 | 9.7e-05 | 0.002879 |
GO:0051336 | regulation of hydrolase activity | 7.69% (7/91) | 2.71 | 0.000101 | 0.00291 |
GO:0044260 | cellular macromolecule metabolic process | 21.98% (20/91) | 1.33 | 0.0001 | 0.002923 |
GO:0036353 | histone H2A-K119 monoubiquitination | 2.2% (2/91) | 6.94 | 0.000112 | 0.003123 |
GO:0004376 | glycolipid mannosyltransferase activity | 2.2% (2/91) | 6.94 | 0.000112 | 0.003123 |
GO:0002066 | columnar/cuboidal epithelial cell development | 2.2% (2/91) | 6.94 | 0.000112 | 0.003123 |
GO:1903305 | regulation of regulated secretory pathway | 3.3% (3/91) | 5.01 | 0.000113 | 0.003131 |
GO:0140096 | catalytic activity, acting on a protein | 24.18% (22/91) | 1.23 | 0.000115 | 0.003153 |
GO:0032527 | protein exit from endoplasmic reticulum | 3.3% (3/91) | 4.97 | 0.000122 | 0.003298 |
GO:0140535 | intracellular protein-containing complex | 10.99% (10/91) | 2.08 | 0.000128 | 0.003425 |
GO:0060548 | negative regulation of cell death | 8.79% (8/91) | 2.41 | 0.000139 | 0.003668 |
GO:0055106 | ubiquitin-protein transferase regulator activity | 3.3% (3/91) | 4.91 | 0.000141 | 0.003682 |
GO:0005515 | protein binding | 57.14% (52/91) | 0.59 | 0.000147 | 0.003795 |
GO:0005765 | lysosomal membrane | 4.4% (4/91) | 3.91 | 0.000151 | 0.003861 |
GO:0030133 | transport vesicle | 5.49% (5/91) | 3.31 | 0.000156 | 0.00394 |
GO:0005773 | vacuole | 14.29% (13/91) | 1.71 | 0.000162 | 0.004014 |
GO:0000030 | mannosyltransferase activity | 3.3% (3/91) | 4.84 | 0.000161 | 0.004046 |
GO:0070382 | exocytic vesicle | 4.4% (4/91) | 3.88 | 0.000167 | 0.004095 |
GO:0001954 | positive regulation of cell-matrix adhesion | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0034452 | dynactin binding | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0036015 | response to interleukin-3 | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0036016 | cellular response to interleukin-3 | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0038034 | signal transduction in absence of ligand | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0071109 | superior temporal gyrus development | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0150101 | regulation of microtubule anchoring at centrosome | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:1904339 | negative regulation of dopaminergic neuron differentiation | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:1990909 | Wnt signalosome | 2.2% (2/91) | 6.58 | 0.000191 | 0.00426 |
GO:0005783 | endoplasmic reticulum | 14.29% (13/91) | 1.68 | 0.000197 | 0.004361 |
GO:0050790 | regulation of catalytic activity | 12.09% (11/91) | 1.87 | 0.000209 | 0.004504 |
GO:0030433 | ubiquitin-dependent ERAD pathway | 4.4% (4/91) | 3.79 | 0.000208 | 0.004523 |
GO:0000152 | nuclear ubiquitin ligase complex | 3.3% (3/91) | 4.72 | 0.000208 | 0.004559 |
GO:0009593 | detection of chemical stimulus | 5.49% (5/91) | 3.21 | 0.000217 | 0.004581 |
GO:1990234 | transferase complex | 10.99% (10/91) | 1.99 | 0.000216 | 0.00461 |
GO:0043227 | membrane-bounded organelle | 53.85% (49/91) | 0.61 | 0.000222 | 0.004658 |
GO:0006621 | protein retention in ER lumen | 2.2% (2/91) | 6.42 | 0.000238 | 0.00479 |
GO:1904781 | positive regulation of protein localization to centrosome | 2.2% (2/91) | 6.42 | 0.000238 | 0.00479 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2.2% (2/91) | 6.42 | 0.000238 | 0.00479 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 2.2% (2/91) | 6.42 | 0.000238 | 0.00479 |
GO:0071840 | cellular component organization or biogenesis | 32.97% (30/91) | 0.92 | 0.000232 | 0.004817 |
GO:0036211 | protein modification process | 23.08% (21/91) | 1.18 | 0.000263 | 0.00525 |
GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.2% (2/91) | 6.29 | 0.000291 | 0.005613 |
GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.2% (2/91) | 6.29 | 0.000291 | 0.005613 |
GO:0010058 | regulation of atrichoblast fate specification | 2.2% (2/91) | 6.29 | 0.000291 | 0.005613 |
GO:0010059 | positive regulation of atrichoblast fate specification | 2.2% (2/91) | 6.29 | 0.000291 | 0.005613 |
GO:0071702 | organic substance transport | 16.48% (15/91) | 1.47 | 0.000308 | 0.0058 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 5.49% (5/91) | 3.1 | 0.000306 | 0.005806 |
GO:0051348 | negative regulation of transferase activity | 4.4% (4/91) | 3.65 | 0.000305 | 0.005836 |
GO:0019646 | aerobic electron transport chain | 3.3% (3/91) | 4.5 | 0.000326 | 0.0061 |
GO:0005768 | endosome | 12.09% (11/91) | 1.79 | 0.000334 | 0.006204 |
GO:0034236 | protein kinase A catalytic subunit binding | 2.2% (2/91) | 6.16 | 0.000348 | 0.00642 |
GO:0044237 | cellular metabolic process | 51.65% (47/91) | 0.61 | 0.000362 | 0.006465 |
GO:0016574 | histone ubiquitination | 3.3% (3/91) | 4.45 | 0.000361 | 0.006504 |
GO:0043412 | macromolecule modification | 25.27% (23/91) | 1.08 | 0.000358 | 0.006544 |
GO:0043231 | intracellular membrane-bounded organelle | 52.75% (48/91) | 0.6 | 0.000361 | 0.006544 |
GO:0071535 | RING-like zinc finger domain binding | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0106057 | negative regulation of calcineurin-mediated signaling | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0030042 | actin filament depolymerization | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0010061 | regulation of trichoblast fate specification | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0010063 | positive regulation of trichoblast fate specification | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:1903888 | regulation of plant epidermal cell differentiation | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:1903890 | positive regulation of plant epidermal cell differentiation | 2.2% (2/91) | 6.05 | 0.000411 | 0.006579 |
GO:0043226 | organelle | 58.24% (53/91) | 0.54 | 0.000371 | 0.006582 |
GO:0045055 | regulated exocytosis | 3.3% (3/91) | 4.42 | 0.000379 | 0.006639 |
GO:0015020 | glucuronosyltransferase activity | 3.3% (3/91) | 4.42 | 0.000379 | 0.006639 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 3.3% (3/91) | 4.38 | 0.000418 | 0.006643 |
GO:0031201 | SNARE complex | 3.3% (3/91) | 4.4 | 0.000398 | 0.006823 |
GO:0009720 | detection of hormone stimulus | 3.3% (3/91) | 4.4 | 0.000398 | 0.006823 |
GO:0009726 | detection of endogenous stimulus | 3.3% (3/91) | 4.4 | 0.000398 | 0.006823 |
GO:0061136 | regulation of proteasomal protein catabolic process | 5.49% (5/91) | 2.99 | 0.000442 | 0.006974 |
GO:0016043 | cellular component organization | 30.77% (28/91) | 0.91 | 0.000456 | 0.007155 |
GO:0008333 | endosome to lysosome transport | 3.3% (3/91) | 4.31 | 0.00048 | 0.007346 |
GO:0001952 | regulation of cell-matrix adhesion | 2.2% (2/91) | 5.94 | 0.000479 | 0.007373 |
GO:0042660 | positive regulation of cell fate specification | 2.2% (2/91) | 5.94 | 0.000479 | 0.007373 |
GO:0031984 | organelle subcompartment | 10.99% (10/91) | 1.84 | 0.000476 | 0.007414 |
GO:0007006 | mitochondrial membrane organization | 3.3% (3/91) | 4.29 | 0.000502 | 0.007587 |
GO:0033365 | protein localization to organelle | 8.79% (8/91) | 2.13 | 0.000501 | 0.007616 |
GO:0008121 | ubiquinol-cytochrome-c reductase activity | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0030137 | COPI-coated vesicle | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0000835 | ER ubiquitin ligase complex | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0000836 | Hrd1p ubiquitin ligase complex | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0030877 | beta-catenin destruction complex | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0050849 | negative regulation of calcium-mediated signaling | 2.2% (2/91) | 5.84 | 0.000552 | 0.007849 |
GO:0071705 | nitrogen compound transport | 14.29% (13/91) | 1.53 | 0.000538 | 0.008082 |
GO:0008152 | metabolic process | 57.14% (52/91) | 0.52 | 0.000577 | 0.00816 |
GO:0031625 | ubiquitin protein ligase binding | 6.59% (6/91) | 2.57 | 0.000551 | 0.008176 |
GO:0010921 | regulation of phosphatase activity | 3.3% (3/91) | 4.24 | 0.000548 | 0.00818 |
GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 4.4% (4/91) | 3.39 | 0.000601 | 0.008449 |
GO:0048489 | synaptic vesicle transport | 2.2% (2/91) | 5.75 | 0.00063 | 0.008462 |
GO:0097479 | synaptic vesicle localization | 2.2% (2/91) | 5.75 | 0.00063 | 0.008462 |
GO:0035437 | maintenance of protein localization in endoplasmic reticulum | 2.2% (2/91) | 5.75 | 0.00063 | 0.008462 |
GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 2.2% (2/91) | 5.75 | 0.00063 | 0.008462 |
GO:0008154 | actin polymerization or depolymerization | 2.2% (2/91) | 5.75 | 0.00063 | 0.008462 |
GO:0018193 | peptidyl-amino acid modification | 9.89% (9/91) | 1.93 | 0.00061 | 0.00848 |
GO:0044089 | positive regulation of cellular component biogenesis | 5.49% (5/91) | 2.88 | 0.000609 | 0.008519 |
GO:0009055 | electron transfer activity | 4.4% (4/91) | 3.36 | 0.000643 | 0.008595 |
GO:0051222 | positive regulation of protein transport | 4.4% (4/91) | 3.37 | 0.000629 | 0.008691 |
GO:0007034 | vacuolar transport | 5.49% (5/91) | 2.86 | 0.000658 | 0.008745 |
GO:0030011 | maintenance of cell polarity | 2.2% (2/91) | 5.66 | 0.000713 | 0.008798 |
GO:1904779 | regulation of protein localization to centrosome | 2.2% (2/91) | 5.66 | 0.000713 | 0.008798 |
GO:0051965 | positive regulation of synapse assembly | 2.2% (2/91) | 5.66 | 0.000713 | 0.008798 |
GO:1901890 | positive regulation of cell junction assembly | 2.2% (2/91) | 5.66 | 0.000713 | 0.008798 |
GO:0000331 | contractile vacuole | 2.2% (2/91) | 5.66 | 0.000713 | 0.008798 |
GO:0043229 | intracellular organelle | 57.14% (52/91) | 0.52 | 0.000668 | 0.008823 |
GO:0008047 | enzyme activator activity | 5.49% (5/91) | 2.85 | 0.000678 | 0.008868 |
GO:0030658 | transport vesicle membrane | 3.3% (3/91) | 4.14 | 0.000675 | 0.00887 |
GO:0033157 | regulation of intracellular protein transport | 4.4% (4/91) | 3.34 | 0.000688 | 0.008894 |
GO:0032984 | protein-containing complex disassembly | 4.4% (4/91) | 3.34 | 0.000688 | 0.008894 |
GO:0044877 | protein-containing complex binding | 9.89% (9/91) | 1.9 | 0.000706 | 0.008936 |
GO:0044389 | ubiquitin-like protein ligase binding | 6.59% (6/91) | 2.5 | 0.000697 | 0.008967 |
GO:0002039 | p53 binding | 3.3% (3/91) | 4.1 | 0.00073 | 0.008967 |
GO:0000151 | ubiquitin ligase complex | 6.59% (6/91) | 2.5 | 0.000705 | 0.008975 |
GO:1990204 | oxidoreductase complex | 4.4% (4/91) | 3.33 | 0.000703 | 0.008995 |
GO:0005829 | cytosol | 27.47% (25/91) | 0.95 | 0.000738 | 0.009018 |
GO:0072665 | protein localization to vacuole | 4.4% (4/91) | 3.3 | 0.00075 | 0.009073 |
GO:0030155 | regulation of cell adhesion | 4.4% (4/91) | 3.3 | 0.00075 | 0.009073 |
GO:0009968 | negative regulation of signal transduction | 10.99% (10/91) | 1.76 | 0.000759 | 0.009141 |
GO:0009966 | regulation of signal transduction | 17.58% (16/91) | 1.28 | 0.00077 | 0.009222 |
GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0036435 | K48-linked polyubiquitin modification-dependent protein binding | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0046902 | regulation of mitochondrial membrane permeability | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0050321 | tau-protein kinase activity | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0034406 | cell wall beta-glucan metabolic process | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0034410 | cell wall beta-glucan biosynthetic process | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0052324 | plant-type cell wall cellulose biosynthetic process | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:0052541 | plant-type cell wall cellulose metabolic process | 2.2% (2/91) | 5.58 | 0.0008 | 0.009227 |
GO:1904951 | positive regulation of establishment of protein localization | 4.4% (4/91) | 3.27 | 0.000816 | 0.009362 |
GO:0051247 | positive regulation of protein metabolic process | 9.89% (9/91) | 1.87 | 0.000824 | 0.009403 |
GO:0045862 | positive regulation of proteolysis | 5.49% (5/91) | 2.78 | 0.000845 | 0.009604 |
GO:0015453 | oxidoreduction-driven active transmembrane transporter activity | 3.3% (3/91) | 4.03 | 0.000849 | 0.009607 |
GO:0044262 | cellular carbohydrate metabolic process | 8.79% (8/91) | 2.01 | 0.000866 | 0.009748 |
GO:0051338 | regulation of transferase activity | 6.59% (6/91) | 2.44 | 0.00088 | 0.009863 |
GO:0048704 | embryonic skeletal system morphogenesis | 2.2% (2/91) | 5.5 | 0.000893 | 0.00992 |
GO:0051018 | protein kinase A binding | 2.2% (2/91) | 5.5 | 0.000893 | 0.00992 |
GO:1900457 | regulation of brassinosteroid mediated signaling pathway | 4.4% (4/91) | 3.23 | 0.000905 | 0.009999 |
GO:0050804 | modulation of chemical synaptic transmission | 4.4% (4/91) | 3.21 | 0.000961 | 0.010525 |
GO:0099177 | regulation of trans-synaptic signaling | 4.4% (4/91) | 3.21 | 0.000961 | 0.010525 |
GO:0023057 | negative regulation of signaling | 10.99% (10/91) | 1.71 | 0.000971 | 0.010594 |
GO:0009653 | anatomical structure morphogenesis | 19.78% (18/91) | 1.15 | 0.000995 | 0.010661 |
GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 2.2% (2/91) | 5.42 | 0.000991 | 0.010665 |
GO:1900271 | regulation of long-term synaptic potentiation | 2.2% (2/91) | 5.42 | 0.000991 | 0.010665 |
GO:0010648 | negative regulation of cell communication | 10.99% (10/91) | 1.71 | 0.000983 | 0.010668 |
GO:0000322 | storage vacuole | 3.3% (3/91) | 3.94 | 0.001015 | 0.010824 |
GO:0015980 | energy derivation by oxidation of organic compounds | 4.4% (4/91) | 3.18 | 0.001039 | 0.011039 |
GO:0043067 | regulation of programmed cell death | 9.89% (9/91) | 1.81 | 0.001094 | 0.011325 |
GO:0106056 | regulation of calcineurin-mediated signaling | 2.2% (2/91) | 5.35 | 0.001094 | 0.011367 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 2.2% (2/91) | 5.35 | 0.001094 | 0.011367 |
GO:0005178 | integrin binding | 2.2% (2/91) | 5.35 | 0.001094 | 0.011367 |
GO:0010071 | root meristem specification | 2.2% (2/91) | 5.35 | 0.001094 | 0.011367 |
GO:0001505 | regulation of neurotransmitter levels | 3.3% (3/91) | 3.91 | 0.001086 | 0.011486 |
GO:1901564 | organonitrogen compound metabolic process | 36.26% (33/91) | 0.74 | 0.001122 | 0.011558 |
GO:1901528 | hydrogen peroxide mediated signaling pathway involved in stomatal movement | 2.2% (2/91) | 5.29 | 0.001201 | 0.012123 |
GO:0006983 | ER overload response | 2.2% (2/91) | 5.29 | 0.001201 | 0.012123 |
GO:0051059 | NF-kappaB binding | 2.2% (2/91) | 5.29 | 0.001201 | 0.012123 |
GO:1904338 | regulation of dopaminergic neuron differentiation | 2.2% (2/91) | 5.29 | 0.001201 | 0.012123 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 2.2% (2/91) | 5.29 | 0.001201 | 0.012123 |
GO:0016757 | glycosyltransferase activity | 8.79% (8/91) | 1.93 | 0.00121 | 0.012162 |
GO:0045785 | positive regulation of cell adhesion | 3.3% (3/91) | 3.84 | 0.001239 | 0.012397 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6.59% (6/91) | 2.34 | 0.001253 | 0.012488 |
GO:0002020 | protease binding | 3.3% (3/91) | 3.82 | 0.001279 | 0.012642 |
GO:0005802 | trans-Golgi network | 7.69% (7/91) | 2.1 | 0.001276 | 0.012662 |
GO:0035518 | histone H2A monoubiquitination | 2.2% (2/91) | 5.22 | 0.001314 | 0.01278 |
GO:0008286 | insulin receptor signaling pathway | 2.2% (2/91) | 5.22 | 0.001314 | 0.01278 |
GO:1904646 | cellular response to amyloid-beta | 2.2% (2/91) | 5.22 | 0.001314 | 0.01278 |
GO:0010455 | positive regulation of cell fate commitment | 2.2% (2/91) | 5.22 | 0.001314 | 0.01278 |
GO:0030425 | dendrite | 4.4% (4/91) | 3.07 | 0.001351 | 0.013035 |
GO:0042752 | regulation of circadian rhythm | 4.4% (4/91) | 3.07 | 0.001351 | 0.013035 |
GO:0090316 | positive regulation of intracellular protein transport | 3.3% (3/91) | 3.79 | 0.001361 | 0.013086 |
GO:0019899 | enzyme binding | 14.29% (13/91) | 1.38 | 0.001367 | 0.013088 |
GO:0022904 | respiratory electron transport chain | 3.3% (3/91) | 3.78 | 0.001404 | 0.013336 |
GO:0048167 | regulation of synaptic plasticity | 3.3% (3/91) | 3.78 | 0.001404 | 0.013336 |
GO:0097191 | extrinsic apoptotic signaling pathway | 2.2% (2/91) | 5.16 | 0.001431 | 0.013489 |
GO:0009953 | dorsal/ventral pattern formation | 2.2% (2/91) | 5.16 | 0.001431 | 0.013489 |
GO:0098803 | respiratory chain complex | 3.3% (3/91) | 3.75 | 0.001491 | 0.01395 |
GO:0016758 | hexosyltransferase activity | 7.69% (7/91) | 2.06 | 0.001486 | 0.013951 |
GO:1905710 | positive regulation of membrane permeability | 2.2% (2/91) | 5.1 | 0.001553 | 0.014416 |
GO:0044306 | neuron projection terminus | 2.2% (2/91) | 5.1 | 0.001553 | 0.014416 |
GO:0006605 | protein targeting | 5.49% (5/91) | 2.58 | 0.001569 | 0.014505 |
GO:0000149 | SNARE binding | 3.3% (3/91) | 3.72 | 0.001582 | 0.014576 |
GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 4.4% (4/91) | 3.01 | 0.001609 | 0.014769 |
GO:0031453 | positive regulation of heterochromatin formation | 2.2% (2/91) | 5.05 | 0.00168 | 0.015076 |
GO:0120263 | positive regulation of heterochromatin organization | 2.2% (2/91) | 5.05 | 0.00168 | 0.015076 |
GO:0001837 | epithelial to mesenchymal transition | 2.2% (2/91) | 5.05 | 0.00168 | 0.015076 |
GO:0043005 | neuron projection | 6.59% (6/91) | 2.25 | 0.001673 | 0.015184 |
GO:0023051 | regulation of signaling | 17.58% (16/91) | 1.18 | 0.001668 | 0.015192 |
GO:0006996 | organelle organization | 17.58% (16/91) | 1.17 | 0.001702 | 0.015218 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.4% (4/91) | 2.99 | 0.001665 | 0.015222 |
GO:0048705 | skeletal system morphogenesis | 2.2% (2/91) | 4.99 | 0.001812 | 0.015848 |
GO:0045665 | negative regulation of neuron differentiation | 2.2% (2/91) | 4.99 | 0.001812 | 0.015848 |
GO:0046827 | positive regulation of protein export from nucleus | 2.2% (2/91) | 4.99 | 0.001812 | 0.015848 |
GO:0006349 | regulation of gene expression by genomic imprinting | 2.2% (2/91) | 4.99 | 0.001812 | 0.015848 |
GO:0070665 | positive regulation of leukocyte proliferation | 2.2% (2/91) | 4.99 | 0.001812 | 0.015848 |
GO:0010646 | regulation of cell communication | 17.58% (16/91) | 1.17 | 0.001796 | 0.015998 |
GO:0010498 | proteasomal protein catabolic process | 6.59% (6/91) | 2.22 | 0.001885 | 0.016435 |
GO:0048156 | tau protein binding | 2.2% (2/91) | 4.94 | 0.001948 | 0.016859 |
GO:1903510 | mucopolysaccharide metabolic process | 2.2% (2/91) | 4.94 | 0.001948 | 0.016859 |
GO:0007041 | lysosomal transport | 3.3% (3/91) | 3.6 | 0.00198 | 0.017078 |
GO:0099523 | presynaptic cytosol | 2.2% (2/91) | 4.89 | 0.002089 | 0.017765 |
GO:0051963 | regulation of synapse assembly | 2.2% (2/91) | 4.89 | 0.002089 | 0.017765 |
GO:0035304 | regulation of protein dephosphorylation | 3.3% (3/91) | 3.58 | 0.002089 | 0.017885 |
GO:1900180 | regulation of protein localization to nucleus | 3.3% (3/91) | 3.58 | 0.002089 | 0.017885 |
GO:0031334 | positive regulation of protein-containing complex assembly | 3.3% (3/91) | 3.56 | 0.002144 | 0.018169 |
GO:1903530 | regulation of secretion by cell | 4.4% (4/91) | 2.89 | 0.002158 | 0.018226 |
GO:0006073 | cellular glucan metabolic process | 5.49% (5/91) | 2.46 | 0.002197 | 0.018488 |
GO:0017005 | 3'-tyrosyl-DNA phosphodiesterase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0070259 | tyrosyl-DNA phosphodiesterase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0001703 | gastrulation with mouth forming first | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0004581 | dolichyl-phosphate beta-glucosyltransferase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0010004 | gastrulation involving germ band extension | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0033164 | glycolipid 1,6-alpha-mannosyltransferase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0106272 | protein localization to ERGIC | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0106273 | cytosol to ERGIC protein transport | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:1902960 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:1905245 | regulation of aspartic-type peptidase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:1905246 | negative regulation of aspartic-type peptidase activity | 1.1% (1/91) | 8.75 | 0.002328 | 0.018564 |
GO:0070069 | cytochrome complex | 2.2% (2/91) | 4.84 | 0.002235 | 0.018743 |
GO:0051050 | positive regulation of transport | 6.59% (6/91) | 2.17 | 0.002251 | 0.018813 |
GO:0070663 | regulation of leukocyte proliferation | 2.2% (2/91) | 4.79 | 0.002385 | 0.018897 |
GO:0030166 | proteoglycan biosynthetic process | 2.2% (2/91) | 4.79 | 0.002385 | 0.018897 |
GO:0043025 | neuronal cell body | 4.4% (4/91) | 2.84 | 0.002439 | 0.019262 |
GO:0044042 | glucan metabolic process | 5.49% (5/91) | 2.45 | 0.002322 | 0.019269 |
GO:1901215 | negative regulation of neuron death | 3.3% (3/91) | 3.52 | 0.002316 | 0.01929 |
GO:0000271 | polysaccharide biosynthetic process | 5.49% (5/91) | 2.43 | 0.002451 | 0.019292 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.2% (2/91) | 4.75 | 0.002541 | 0.019553 |
GO:1905269 | positive regulation of chromatin organization | 2.2% (2/91) | 4.75 | 0.002541 | 0.019553 |
GO:0048762 | mesenchymal cell differentiation | 2.2% (2/91) | 4.75 | 0.002541 | 0.019553 |
GO:0090559 | regulation of membrane permeability | 2.2% (2/91) | 4.75 | 0.002541 | 0.019553 |
GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 2.2% (2/91) | 4.75 | 0.002541 | 0.019553 |
GO:0000792 | heterochromatin | 3.3% (3/91) | 3.49 | 0.002496 | 0.019585 |
GO:0022900 | electron transport chain | 4.4% (4/91) | 2.83 | 0.002513 | 0.019655 |
GO:0065009 | regulation of molecular function | 13.19% (12/91) | 1.35 | 0.002582 | 0.01975 |
GO:1902531 | regulation of intracellular signal transduction | 8.79% (8/91) | 1.76 | 0.002576 | 0.019762 |
GO:0035303 | regulation of dephosphorylation | 3.3% (3/91) | 3.46 | 0.002621 | 0.019923 |
GO:0017157 | regulation of exocytosis | 3.3% (3/91) | 3.46 | 0.002621 | 0.019923 |
GO:0006984 | ER-nucleus signaling pathway | 2.2% (2/91) | 4.7 | 0.0027 | 0.020333 |
GO:0106027 | neuron projection organization | 2.2% (2/91) | 4.7 | 0.0027 | 0.020333 |
GO:1904645 | response to amyloid-beta | 2.2% (2/91) | 4.7 | 0.0027 | 0.020333 |
GO:0045121 | membrane raft | 3.3% (3/91) | 3.44 | 0.00275 | 0.02058 |
GO:0009100 | glycoprotein metabolic process | 3.3% (3/91) | 3.44 | 0.00275 | 0.02058 |
GO:0051049 | regulation of transport | 10.99% (10/91) | 1.5 | 0.002781 | 0.020683 |
GO:0044264 | cellular polysaccharide metabolic process | 6.59% (6/91) | 2.11 | 0.002781 | 0.020744 |
GO:0098857 | membrane microdomain | 3.3% (3/91) | 3.42 | 0.002816 | 0.02088 |
GO:0010811 | positive regulation of cell-substrate adhesion | 2.2% (2/91) | 4.66 | 0.002865 | 0.02105 |
GO:0050848 | regulation of calcium-mediated signaling | 2.2% (2/91) | 4.66 | 0.002865 | 0.02105 |
GO:1900181 | negative regulation of protein localization to nucleus | 2.2% (2/91) | 4.66 | 0.002865 | 0.02105 |
GO:0051046 | regulation of secretion | 4.4% (4/91) | 2.77 | 0.002907 | 0.021293 |
GO:0043254 | regulation of protein-containing complex assembly | 4.4% (4/91) | 2.76 | 0.00299 | 0.021838 |
GO:0006887 | exocytosis | 3.3% (3/91) | 3.39 | 0.003019 | 0.021984 |
GO:0046777 | protein autophosphorylation | 8.79% (8/91) | 1.72 | 0.00304 | 0.022003 |
GO:0033522 | histone H2A ubiquitination | 2.2% (2/91) | 4.62 | 0.003034 | 0.022026 |
GO:0071704 | organic substance metabolic process | 51.65% (47/91) | 0.48 | 0.003055 | 0.022047 |
GO:0030136 | clathrin-coated vesicle | 3.3% (3/91) | 3.38 | 0.003089 | 0.022225 |
GO:0042176 | regulation of protein catabolic process | 5.49% (5/91) | 2.34 | 0.003148 | 0.022514 |
GO:0006807 | nitrogen compound metabolic process | 41.76% (38/91) | 0.58 | 0.003145 | 0.022561 |
GO:0060627 | regulation of vesicle-mediated transport | 5.49% (5/91) | 2.34 | 0.003211 | 0.02277 |
GO:0010390 | histone monoubiquitination | 2.2% (2/91) | 4.58 | 0.003208 | 0.02281 |
GO:0046825 | regulation of protein export from nucleus | 2.2% (2/91) | 4.58 | 0.003208 | 0.02281 |
GO:0032388 | positive regulation of intracellular transport | 3.3% (3/91) | 3.34 | 0.003304 | 0.02329 |
GO:0050807 | regulation of synapse organization | 3.3% (3/91) | 3.34 | 0.003304 | 0.02329 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 2.2% (2/91) | 4.54 | 0.003386 | 0.023661 |
GO:0014743 | regulation of muscle hypertrophy | 2.2% (2/91) | 4.54 | 0.003386 | 0.023661 |
GO:0006024 | glycosaminoglycan biosynthetic process | 2.2% (2/91) | 4.54 | 0.003386 | 0.023661 |
GO:0009060 | aerobic respiration | 3.3% (3/91) | 3.32 | 0.003452 | 0.024056 |
GO:0006513 | protein monoubiquitination | 3.3% (3/91) | 3.31 | 0.003528 | 0.024513 |
GO:0021766 | hippocampus development | 2.2% (2/91) | 4.5 | 0.003568 | 0.024516 |
GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 2.2% (2/91) | 4.5 | 0.003568 | 0.024516 |
GO:0040007 | growth | 13.19% (12/91) | 1.29 | 0.003548 | 0.024581 |
GO:0010941 | regulation of cell death | 9.89% (9/91) | 1.56 | 0.003564 | 0.024626 |
GO:0097190 | apoptotic signaling pathway | 3.3% (3/91) | 3.3 | 0.003604 | 0.024693 |
GO:0061024 | membrane organization | 6.59% (6/91) | 2.03 | 0.003617 | 0.024707 |
GO:0016301 | kinase activity | 13.19% (12/91) | 1.29 | 0.003643 | 0.024819 |
GO:0006623 | protein targeting to vacuole | 3.3% (3/91) | 3.29 | 0.003682 | 0.025014 |
GO:0000902 | cell morphogenesis | 10.99% (10/91) | 1.44 | 0.003713 | 0.025153 |
GO:0050839 | cell adhesion molecule binding | 2.2% (2/91) | 4.46 | 0.003756 | 0.025232 |
GO:0006023 | aminoglycan biosynthetic process | 2.2% (2/91) | 4.46 | 0.003756 | 0.025232 |
GO:0099503 | secretory vesicle | 4.4% (4/91) | 2.66 | 0.003766 | 0.025234 |
GO:0044248 | cellular catabolic process | 15.38% (14/91) | 1.16 | 0.003753 | 0.025357 |
GO:0032386 | regulation of intracellular transport | 4.4% (4/91) | 2.66 | 0.003816 | 0.025495 |
GO:0044265 | cellular macromolecule catabolic process | 8.79% (8/91) | 1.66 | 0.003835 | 0.02555 |
GO:0071588 | hydrogen peroxide mediated signaling pathway | 2.2% (2/91) | 4.42 | 0.003947 | 0.026016 |
GO:0045639 | positive regulation of myeloid cell differentiation | 2.2% (2/91) | 4.42 | 0.003947 | 0.026016 |
GO:1902107 | positive regulation of leukocyte differentiation | 2.2% (2/91) | 4.42 | 0.003947 | 0.026016 |
GO:1903708 | positive regulation of hemopoiesis | 2.2% (2/91) | 4.42 | 0.003947 | 0.026016 |
GO:0044297 | cell body | 4.4% (4/91) | 2.63 | 0.00407 | 0.026753 |
GO:0062207 | regulation of pattern recognition receptor signaling pathway | 2.2% (2/91) | 4.39 | 0.004144 | 0.027017 |
GO:0010810 | regulation of cell-substrate adhesion | 2.2% (2/91) | 4.39 | 0.004144 | 0.027017 |
GO:1901888 | regulation of cell junction assembly | 2.2% (2/91) | 4.39 | 0.004144 | 0.027017 |
GO:0051603 | proteolysis involved in protein catabolic process | 7.69% (7/91) | 1.79 | 0.00422 | 0.027443 |
GO:0033697 | obsolete positive regulation of extent of heterochromatin assembly | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:1905632 | protein localization to euchromatin | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:1905644 | regulation of FACT complex assembly | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:1905646 | positive regulation of FACT complex assembly | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:1990226 | histone methyltransferase binding | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0000837 | Doa10p ubiquitin ligase complex | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0006274 | DNA replication termination | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0036501 | UFD1-NPL4 complex | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0030713 | ovarian follicle cell stalk formation | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0032330 | regulation of chondrocyte differentiation | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0033339 | pectoral fin development | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0048263 | determination of dorsal identity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0010543 | regulation of platelet activation | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0035408 | obsolete histone H3-T6 phosphorylation | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0035866 | alphav-beta3 integrin-PKCalpha complex | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0045780 | positive regulation of bone resorption | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0050930 | induction of positive chemotaxis | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0051412 | response to corticosterone | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0090330 | regulation of platelet aggregation | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:1990911 | response to psychosocial stress | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:2000705 | regulation of dense core granule biogenesis | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:2000707 | positive regulation of dense core granule biogenesis | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0019991 | septate junction assembly | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0000009 | alpha-1,6-mannosyltransferase activity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0106262 | 1-acylglycerophosphoethanolamine O-acyltransferase activity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0106263 | 1-acylglycerophosphoserine O-acyltransferase activity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0004377 | GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:2000157 | negative regulation of ubiquitin-specific protease activity | 1.1% (1/91) | 7.75 | 0.004651 | 0.027587 |
GO:0032881 | regulation of polysaccharide metabolic process | 4.4% (4/91) | 2.61 | 0.004282 | 0.027767 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 3.3% (3/91) | 3.16 | 0.004695 | 0.02778 |
GO:0009729 | detection of brassinosteroid stimulus | 2.2% (2/91) | 4.29 | 0.004759 | 0.027887 |
GO:0010822 | positive regulation of mitochondrion organization | 2.2% (2/91) | 4.29 | 0.004759 | 0.027887 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 2.2% (2/91) | 4.29 | 0.004759 | 0.027887 |
GO:0002064 | epithelial cell development | 2.2% (2/91) | 4.29 | 0.004759 | 0.027887 |
GO:0030234 | enzyme regulator activity | 7.69% (7/91) | 1.76 | 0.004771 | 0.027891 |
GO:0045333 | cellular respiration | 3.3% (3/91) | 3.15 | 0.004786 | 0.027912 |
GO:0072595 | maintenance of protein localization in organelle | 2.2% (2/91) | 4.35 | 0.004344 | 0.028024 |
GO:0009933 | meristem structural organization | 2.2% (2/91) | 4.35 | 0.004344 | 0.028024 |
GO:0051246 | regulation of protein metabolic process | 13.19% (12/91) | 1.25 | 0.004421 | 0.028442 |
GO:0031399 | regulation of protein modification process | 8.79% (8/91) | 1.63 | 0.004464 | 0.028644 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 2.2% (2/91) | 4.25 | 0.004973 | 0.028931 |
GO:0099522 | cytosolic region | 2.2% (2/91) | 4.32 | 0.004549 | 0.028963 |
GO:0048562 | embryonic organ morphogenesis | 2.2% (2/91) | 4.32 | 0.004549 | 0.028963 |
GO:0043502 | regulation of muscle adaptation | 2.2% (2/91) | 4.32 | 0.004549 | 0.028963 |
GO:0016310 | phosphorylation | 12.09% (11/91) | 1.29 | 0.005115 | 0.029687 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.3% (3/91) | 3.11 | 0.005161 | 0.029887 |
GO:0048660 | regulation of smooth muscle cell proliferation | 2.2% (2/91) | 4.22 | 0.005191 | 0.029985 |
GO:0032182 | ubiquitin-like protein binding | 3.3% (3/91) | 3.09 | 0.005356 | 0.030865 |
GO:0005976 | polysaccharide metabolic process | 7.69% (7/91) | 1.73 | 0.005374 | 0.030898 |
GO:0045216 | cell-cell junction organization | 2.2% (2/91) | 4.19 | 0.005413 | 0.030904 |
GO:0098685 | Schaffer collateral - CA1 synapse | 2.2% (2/91) | 4.19 | 0.005413 | 0.030904 |
GO:0005484 | SNAP receptor activity | 2.2% (2/91) | 4.19 | 0.005413 | 0.030904 |
GO:0016049 | cell growth | 10.99% (10/91) | 1.36 | 0.005437 | 0.030966 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:0018210 | peptidyl-threonine modification | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:0048814 | regulation of dendrite morphogenesis | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:1900458 | negative regulation of brassinosteroid mediated signaling pathway | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:0051261 | protein depolymerization | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:0009101 | glycoprotein biosynthetic process | 2.2% (2/91) | 4.16 | 0.00564 | 0.031533 |
GO:0045335 | phagocytic vesicle | 3.3% (3/91) | 3.07 | 0.005554 | 0.03156 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 12.09% (11/91) | 1.28 | 0.005602 | 0.031758 |
GO:1902911 | protein kinase complex | 3.3% (3/91) | 3.06 | 0.005757 | 0.032113 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 2.2% (2/91) | 4.13 | 0.005871 | 0.032452 |
GO:0008013 | beta-catenin binding | 2.2% (2/91) | 4.13 | 0.005871 | 0.032452 |
GO:0004190 | aspartic-type endopeptidase activity | 2.2% (2/91) | 4.13 | 0.005871 | 0.032452 |
GO:1903828 | negative regulation of protein localization | 3.3% (3/91) | 3.05 | 0.00586 | 0.032613 |
GO:0098800 | inner mitochondrial membrane protein complex | 3.3% (3/91) | 3.04 | 0.005964 | 0.032892 |
GO:0072666 | establishment of protein localization to vacuole | 3.3% (3/91) | 3.03 | 0.00607 | 0.033398 |
GO:0051606 | detection of stimulus | 5.49% (5/91) | 2.11 | 0.006188 | 0.033974 |
GO:0000323 | lytic vacuole | 4.4% (4/91) | 2.46 | 0.006245 | 0.034209 |
GO:0000153 | cytoplasmic ubiquitin ligase complex | 2.2% (2/91) | 4.07 | 0.006346 | 0.034452 |
GO:0032092 | positive regulation of protein binding | 2.2% (2/91) | 4.07 | 0.006346 | 0.034452 |
GO:0000326 | protein storage vacuole | 2.2% (2/91) | 4.07 | 0.006346 | 0.034452 |
GO:0042127 | regulation of cell population proliferation | 7.69% (7/91) | 1.68 | 0.006313 | 0.034501 |
GO:0043085 | positive regulation of catalytic activity | 5.49% (5/91) | 2.1 | 0.006396 | 0.034645 |
GO:0034773 | histone H4-K20 trimethylation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:1990112 | RQC complex | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0001739 | sex chromatin | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0030708 | germarium-derived female germ-line cyst encapsulation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0048139 | female germ-line cyst encapsulation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0061035 | regulation of cartilage development | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0010829 | negative regulation of glucose transmembrane transport | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0045649 | regulation of macrophage differentiation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0045651 | positive regulation of macrophage differentiation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0046325 | negative regulation of glucose import | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0048265 | response to pain | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0035701 | hematopoietic stem cell migration | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0060819 | inactivation of X chromosome by genomic imprinting | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0004378 | GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0016992 | lipoate synthase activity | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0102552 | obsolete lipoyl synthase activity (acting on glycine-cleavage complex H protein | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0102553 | obsolete lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0000026 | alpha-1,2-mannosyltransferase activity | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0035964 | COPI-coated vesicle budding | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0070765 | gamma-secretase complex | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0000320 | re-entry into mitotic cell cycle | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0014043 | negative regulation of neuron maturation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0033690 | positive regulation of osteoblast proliferation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0034392 | negative regulation of smooth muscle cell apoptotic process | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0035733 | hepatic stellate cell activation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0045672 | positive regulation of osteoclast differentiation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0046849 | bone remodeling | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0090289 | regulation of osteoclast proliferation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0090290 | positive regulation of osteoclast proliferation | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0071796 | K6-linked polyubiquitin modification-dependent protein binding | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:1903093 | regulation of protein K48-linked deubiquitination | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:1903094 | negative regulation of protein K48-linked deubiquitination | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:1904855 | proteasome regulatory particle binding | 1.1% (1/91) | 7.16 | 0.006968 | 0.034656 |
GO:0031445 | regulation of heterochromatin formation | 2.2% (2/91) | 3.99 | 0.007091 | 0.03505 |
GO:0120261 | regulation of heterochromatin organization | 2.2% (2/91) | 3.99 | 0.007091 | 0.03505 |
GO:0140030 | modification-dependent protein binding | 3.3% (3/91) | 2.95 | 0.007068 | 0.03508 |
GO:0022411 | cellular component disassembly | 4.4% (4/91) | 2.4 | 0.007114 | 0.035094 |
GO:0009057 | macromolecule catabolic process | 9.89% (9/91) | 1.4 | 0.007152 | 0.035208 |
GO:0033692 | cellular polysaccharide biosynthetic process | 4.4% (4/91) | 2.4 | 0.00719 | 0.035324 |
GO:0005102 | signaling receptor binding | 5.49% (5/91) | 2.09 | 0.006555 | 0.035428 |
GO:0006029 | proteoglycan metabolic process | 2.2% (2/91) | 4.05 | 0.00659 | 0.035538 |
GO:1901575 | organic substance catabolic process | 15.38% (14/91) | 1.05 | 0.007252 | 0.03556 |
GO:0016050 | vesicle organization | 4.4% (4/91) | 2.43 | 0.00667 | 0.03589 |
GO:0001775 | cell activation | 3.3% (3/91) | 2.97 | 0.006725 | 0.036105 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 2.2% (2/91) | 4.02 | 0.006838 | 0.036552 |
GO:0006487 | protein N-linked glycosylation | 2.2% (2/91) | 4.02 | 0.006838 | 0.036552 |
GO:0051130 | positive regulation of cellular component organization | 6.59% (6/91) | 1.81 | 0.007535 | 0.036874 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.59% (6/91) | 1.81 | 0.007583 | 0.037034 |
GO:0030203 | glycosaminoglycan metabolic process | 2.2% (2/91) | 3.94 | 0.007608 | 0.037079 |
GO:0010383 | cell wall polysaccharide metabolic process | 4.4% (4/91) | 2.37 | 0.007656 | 0.037237 |
GO:0019941 | modification-dependent protein catabolic process | 6.59% (6/91) | 1.8 | 0.007777 | 0.037753 |
GO:0030173 | integral component of Golgi membrane | 2.2% (2/91) | 3.91 | 0.007873 | 0.03814 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 13.19% (12/91) | 1.14 | 0.007938 | 0.038382 |
GO:0003935 | GTP cyclohydrolase II activity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0005701 | polytene chromosome chromocenter | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0045857 | obsolete negative regulation of molecular function, epigenetic | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0003159 | morphogenesis of an endothelium | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0008062 | eclosion rhythm | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0061154 | endothelial tube morphogenesis | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033130 | acetylcholine receptor binding | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0071340 | skeletal muscle acetylcholine-gated channel clustering | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0039536 | negative regulation of RIG-I signaling pathway | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0044305 | calyx of Held | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0045124 | regulation of bone resorption | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0010620 | negative regulation of transcription by transcription factor catabolism | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0021903 | rostrocaudal neural tube patterning | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033083 | regulation of immature T cell proliferation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0004149 | dihydrolipoyllysine-residue succinyltransferase activity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0016748 | succinyltransferase activity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0016751 | S-succinyltransferase activity | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0019474 | L-lysine catabolic process to acetyl-CoA | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0033688 | regulation of osteoblast proliferation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0044026 | DNA hypermethylation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0044027 | hypermethylation of CpG island | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0045886 | negative regulation of synaptic assembly at neuromuscular junction | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0051964 | negative regulation of synapse assembly | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0072537 | fibroblast activation | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:1904397 | negative regulation of neuromuscular junction development | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:2001222 | regulation of neuron migration | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:2001223 | negative regulation of neuron migration | 1.1% (1/91) | 6.75 | 0.00928 | 0.04052 |
GO:0005884 | actin filament | 2.2% (2/91) | 3.86 | 0.008415 | 0.040604 |
GO:0019787 | ubiquitin-like protein transferase activity | 6.59% (6/91) | 1.77 | 0.008537 | 0.041111 |
GO:0009825 | multidimensional cell growth | 3.3% (3/91) | 2.79 | 0.009479 | 0.041315 |
GO:0005654 | nucleoplasm | 10.99% (10/91) | 1.27 | 0.008598 | 0.041324 |
GO:0080171 | lytic vacuole organization | 2.2% (2/91) | 3.77 | 0.009547 | 0.041388 |
GO:0050773 | regulation of dendrite development | 2.2% (2/91) | 3.77 | 0.009547 | 0.041388 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 2.2% (2/91) | 3.77 | 0.009547 | 0.041388 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 2.2% (2/91) | 3.84 | 0.008692 | 0.041529 |
GO:1902105 | regulation of leukocyte differentiation | 2.2% (2/91) | 3.84 | 0.008692 | 0.041529 |
GO:0004672 | protein kinase activity | 10.99% (10/91) | 1.27 | 0.008662 | 0.04155 |
GO:0009056 | catabolic process | 16.48% (15/91) | 0.95 | 0.009687 | 0.04192 |
GO:0006796 | phosphate-containing compound metabolic process | 16.48% (15/91) | 0.97 | 0.008974 | 0.042545 |
GO:0048589 | developmental growth | 10.99% (10/91) | 1.26 | 0.009022 | 0.042605 |
GO:1901214 | regulation of neuron death | 3.3% (3/91) | 2.82 | 0.008937 | 0.042616 |
GO:0007369 | gastrulation | 2.2% (2/91) | 3.82 | 0.008973 | 0.042621 |
GO:1901216 | positive regulation of neuron death | 2.2% (2/91) | 3.82 | 0.008973 | 0.042621 |
GO:0044087 | regulation of cellular component biogenesis | 6.59% (6/91) | 1.75 | 0.009017 | 0.042664 |
GO:0006091 | generation of precursor metabolites and energy | 5.49% (5/91) | 1.94 | 0.009914 | 0.042751 |
GO:0070592 | cell wall polysaccharide biosynthetic process | 3.3% (3/91) | 2.77 | 0.009899 | 0.042759 |
GO:0034097 | response to cytokine | 4.4% (4/91) | 2.3 | 0.009083 | 0.042809 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.59% (6/91) | 1.75 | 0.009181 | 0.04319 |
GO:0000791 | euchromatin | 2.2% (2/91) | 3.79 | 0.009258 | 0.043216 |
GO:0007040 | lysosome organization | 2.2% (2/91) | 3.79 | 0.009258 | 0.043216 |
GO:0032091 | negative regulation of protein binding | 2.2% (2/91) | 3.79 | 0.009258 | 0.043216 |
GO:0009250 | glucan biosynthetic process | 3.3% (3/91) | 2.81 | 0.009206 | 0.043221 |
GO:0070001 | aspartic-type peptidase activity | 2.2% (2/91) | 3.72 | 0.010137 | 0.043636 |
GO:0051345 | positive regulation of hydrolase activity | 3.3% (3/91) | 2.75 | 0.010184 | 0.043759 |
GO:0031072 | heat shock protein binding | 3.3% (3/91) | 2.75 | 0.010329 | 0.044302 |
GO:0031228 | intrinsic component of Golgi membrane | 2.2% (2/91) | 3.7 | 0.010439 | 0.044538 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 2.2% (2/91) | 3.7 | 0.010439 | 0.044538 |
GO:0006793 | phosphorus metabolic process | 16.48% (15/91) | 0.94 | 0.010418 | 0.044605 |
GO:1901800 | positive regulation of proteasomal protein catabolic process | 3.3% (3/91) | 2.74 | 0.010474 | 0.044612 |
GO:0006099 | tricarboxylic acid cycle | 2.2% (2/91) | 3.68 | 0.010744 | 0.045679 |
GO:0048522 | positive regulation of cellular process | 23.08% (21/91) | 0.74 | 0.011602 | 0.045881 |
GO:0032925 | regulation of activin receptor signaling pathway | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0032927 | positive regulation of activin receptor signaling pathway | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0090052 | regulation of pericentric heterochromatin formation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0090053 | positive regulation of pericentric heterochromatin formation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:1903958 | nitric-oxide synthase complex | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0043113 | receptor clustering | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0033333 | fin development | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0045498 | sex comb development | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0000104 | succinate dehydrogenase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0008177 | succinate dehydrogenase (ubiquinone) activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0032423 | regulation of mismatch repair | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0032425 | positive regulation of mismatch repair | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0050927 | positive regulation of positive chemotaxis | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0060291 | long-term synaptic potentiation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:1903859 | regulation of dendrite extension | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:1903861 | positive regulation of dendrite extension | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0004576 | oligosaccharyl transferase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0042074 | cell migration involved in gastrulation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0090130 | tissue migration | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0120192 | tight junction assembly | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0120193 | tight junction organization | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0036369 | transcription factor catabolic process | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0035560 | pheophorbidase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0032732 | positive regulation of interleukin-1 production | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0042589 | zymogen granule membrane | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0032769 | negative regulation of monooxygenase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0050999 | regulation of nitric-oxide synthase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0097284 | hepatocyte apoptotic process | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:2000171 | negative regulation of dendrite development | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:2000463 | positive regulation of excitatory postsynaptic potential | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1.1% (1/91) | 6.42 | 0.011587 | 0.045895 |
GO:0044038 | cell wall macromolecule biosynthetic process | 3.3% (3/91) | 2.68 | 0.011683 | 0.045975 |
GO:0070589 | cellular component macromolecule biosynthetic process | 3.3% (3/91) | 2.68 | 0.011683 | 0.045975 |
GO:0010721 | negative regulation of cell development | 2.2% (2/91) | 3.62 | 0.011682 | 0.046121 |
GO:0006468 | protein phosphorylation | 9.89% (9/91) | 1.3 | 0.010955 | 0.046497 |
GO:0051235 | maintenance of location | 3.3% (3/91) | 2.67 | 0.011839 | 0.046516 |
GO:0030336 | negative regulation of cell migration | 2.2% (2/91) | 3.6 | 0.012003 | 0.04678 |
GO:0031901 | early endosome membrane | 2.2% (2/91) | 3.6 | 0.012003 | 0.04678 |
GO:2000067 | regulation of root morphogenesis | 2.2% (2/91) | 3.66 | 0.011053 | 0.046829 |
GO:0098978 | glutamatergic synapse | 3.3% (3/91) | 2.67 | 0.011997 | 0.046908 |
GO:0051346 | negative regulation of hydrolase activity | 3.3% (3/91) | 2.67 | 0.011997 | 0.046908 |
GO:0031401 | positive regulation of protein modification process | 5.49% (5/91) | 1.88 | 0.011972 | 0.046961 |
GO:0010638 | positive regulation of organelle organization | 4.4% (4/91) | 2.18 | 0.012111 | 0.047127 |
GO:0000139 | Golgi membrane | 5.49% (5/91) | 1.87 | 0.012217 | 0.047464 |
GO:0030111 | regulation of Wnt signaling pathway | 3.3% (3/91) | 2.69 | 0.011373 | 0.048105 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 4.4% (4/91) | 2.17 | 0.012435 | 0.048231 |
GO:0009967 | positive regulation of signal transduction | 7.69% (7/91) | 1.49 | 0.012466 | 0.048276 |
GO:0050794 | regulation of cellular process | 40.66% (37/91) | 0.48 | 0.012546 | 0.048507 |
GO:2000146 | negative regulation of cell motility | 2.2% (2/91) | 3.56 | 0.012655 | 0.048622 |
GO:0032507 | maintenance of protein location in cell | 2.2% (2/91) | 3.56 | 0.012655 | 0.048622 |
GO:0090421 | embryonic meristem initiation | 2.2% (2/91) | 3.56 | 0.012655 | 0.048622 |
GO:0042995 | cell projection | 8.79% (8/91) | 1.37 | 0.01262 | 0.048716 |
GO:0016051 | carbohydrate biosynthetic process | 5.49% (5/91) | 1.85 | 0.012718 | 0.048786 |
GO:0098772 | molecular function regulator activity | 7.69% (7/91) | 1.48 | 0.012822 | 0.049108 |
GO:0003400 | regulation of COPII vesicle coating | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0090113 | regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0048733 | sebaceous gland development | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0061665 | SUMO ligase activity | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0034456 | UTP-C complex | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0030123 | AP-3 adaptor complex | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0048490 | anterograde synaptic vesicle transport | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0099514 | synaptic vesicle cytoskeletal transport | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0099517 | synaptic vesicle transport along microtubule | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0007212 | dopamine receptor signaling pathway | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:2000074 | regulation of type B pancreatic cell development | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0002327 | immature B cell differentiation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0036335 | intestinal stem cell homeostasis | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0002062 | chondrocyte differentiation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0034103 | regulation of tissue remodeling | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0045822 | negative regulation of heart contraction | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0046850 | regulation of bone remodeling | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0099171 | presynaptic modulation of chemical synaptic transmission | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:1903523 | negative regulation of blood circulation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:1990504 | dense core granule exocytosis | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0008078 | mesodermal cell migration | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0072546 | EMC complex | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0030041 | actin filament polymerization | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0019477 | L-lysine catabolic process | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0046440 | L-lysine metabolic process | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0035372 | protein localization to microtubule | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0045670 | regulation of osteoclast differentiation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:1903430 | negative regulation of cell maturation | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:1905809 | negative regulation of synapse organization | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0090086 | negative regulation of protein deubiquitination | 1.1% (1/91) | 6.16 | 0.013888 | 0.049237 |
GO:0030516 | regulation of axon extension | 2.2% (2/91) | 3.54 | 0.012987 | 0.049352 |
GO:0006469 | negative regulation of protein kinase activity | 2.2% (2/91) | 3.54 | 0.012987 | 0.049352 |
GO:0031396 | regulation of protein ubiquitination | 3.3% (3/91) | 2.62 | 0.012969 | 0.049435 |
GO:0006486 | protein glycosylation | 3.3% (3/91) | 2.62 | 0.012969 | 0.049435 |
GO:0043413 | macromolecule glycosylation | 3.3% (3/91) | 2.62 | 0.012969 | 0.049435 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 2.2% (2/91) | 3.48 | 0.014006 | 0.049438 |
GO:0010821 | regulation of mitochondrion organization | 2.2% (2/91) | 3.48 | 0.014006 | 0.049438 |
GO:0031985 | Golgi cisterna | 2.2% (2/91) | 3.48 | 0.014006 | 0.049438 |
GO:0031400 | negative regulation of protein modification process | 4.4% (4/91) | 2.14 | 0.013098 | 0.049695 |
GO:0030139 | endocytic vesicle | 3.3% (3/91) | 2.62 | 0.013135 | 0.049757 |